Concurrent cisplatin and radiotherapy in advanced head and neck cancer

被引：4
|
作者：
Rehan Asif
Kamlesh Chandra
Vanita Chopra
M. L. B. Bhatt
机构：
[1] Deptt of Otorhmolaryngology,Deptt of Radiotherapy
[2] J N M C Hospital,undefined
[3] A.M U,undefined
来源：
Indian Journal of Otolaryngology and Head and Neck Surgery | 2003年 / 55卷 / 2期
关键词：
Neck Cancer; Bleomycin; Local Tumor Control; Local Tumor Recurrence; Concomitant Chemotherapy;
D O I：
10.1007/BF02974612
中图分类号：
学科分类号：
摘要：
Management of Head and Neck Cancers poses a challenge inspite of several advances because of poor success in terms of response rate, survival and reduced morbidity of the patients. In the present study 30 untreated histologically proven cases of head and neck cancers were subjected to weekly radiotherapy with adjuvant chemotherapy (cisplatin 30 mg/m2 intravenously). This study group was compared with a group of 30 patients who were given only radiotherapy. Results have shown that combination of chemotherapy with radiotherapy gives a significantly better results in tumour as well as nodal response with minimal toxicities.
引用
收藏
页码：94 / 96
页数：2
相关论文
共 50 条
  • [1] Alternating chemotherapy: Gemcitabine and cisplatin with concurrent radiotherapy for treatment of advanced head and neck cancer
    Aguilar-Ponce, J. L.
    Granados-Garcia, M.
    Cruz Lopez, J. C.
    Maldonado-Magos, F.
    Alvarez-Avitia, M. A.
    Arrieta, O.
    Gonzalez-Ramirez, I.
    Lara-Cruz, G.
    Martinez-Juarez, I.
    Medina-Santillan, R.
    Castillo-Hernandez, C.
    De la Garza-Salazar, J.
    ORAL ONCOLOGY, 2013, 49 (03) : 249 - 254
  • [2] Conventional vs concomitant boost radiotherapy with concurrent cisplatin in advanced head and neck cancer
    Meshram, Sushil Dashrath
    Kamble, Krishna M.
    Diwan, Ashok K.
    Mohobia, Vijay K.
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2015, 11 (04) : 770 - 774
  • [3] Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer
    Rischin, D
    Peters, L
    Hicks, R
    Hughes, P
    Fisher, R
    Hart, R
    Sexton, M
    D'Costa, I
    von Roemeling, R
    JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (02) : 535 - 542
  • [4] Community outcomes: Hyperfractionated radiotherapy with concurrent cisplatin and locally-advanced head and neck cancer
    Maguire, PD
    CANCER JOURNAL, 2002, 8 (06): : 500 - 501
  • [5] Concurrent, cisplatin-based chemotherapy with accelerated radiotherapy for advanced head and neck cancer patients
    Skladowski, K. A., Sr.
    Rutkowski, T.
    Wygoda, A.
    Golen, M.
    Pilecki, B.
    Przeorek, W.
    Lukaszczyk-Widel, B.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [6] Hyperfractionated radiotherapy with concurrent docetaxel for advanced head and neck cancer
    Karasawa, K.
    Ito, K.
    Takada, T.
    Matsumoto, F.
    Haruyama, T.
    Ito, S.
    Ikeda, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (03): : S450 - S451
  • [7] CISPLATIN AND RADIOTHERAPY IN THE MANAGEMENT OF LOCALLY ADVANCED HEAD AND NECK-CANCER
    FORASTIERE, AA
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 27 (02): : 465 - 470
  • [8] Postoperative radiotherapy with weekly cisplatin in locally advanced head and neck cancer
    Hervas, A.
    Dominguez, J.
    Candini, D.
    Martin, M.
    Vallejo, C.
    ANNALS OF ONCOLOGY, 2017, 28
  • [9] Six-fractions-a-week radiotherapy along with concurrent weekly cisplatin in locally advanced head and neck cancer
    Kumar, S.
    Bajpai, R.
    Rastogi, N.
    Das, K. J. Maria
    Lal, P.
    RADIOTHERAPY AND ONCOLOGY, 2007, 82 : S76 - S76
  • [10] CONCURRENT VINORELBINE VS. CISPLATIN WITH RADIOTHERAPY IN TREATMENT OF LOCALLY ADVANCED HEAD AND NECK CANCER: EFFICACY AND TOXICITY
    Abdel-Wahab, S.
    Azmy, A.
    Salem, H. Abd Alla
    Abul-Aziz, H.
    Abdel-Fatah, A.
    RADIOTHERAPY AND ONCOLOGY, 2009, 92 : S143 - S144
12345